Molina Healthcare, Inc.
HealthcareNYSE:MOH · New York Stock Exchange
+$6.75 today
Vol 1.18M · Avg 1.40M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$45.1B of revenue converted into $188.0M of net income for the selected period. Gross margin is 8.5% and net margin is 0.4%, showing how much revenue survives after costs and taxes. EPS is $3.36, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.4B +11.7% | $40.6B +19.3% | $34.1B +6.6% | $32.0B +15.1% | $27.8B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $41.4B +15.1% | $35.9B +20.8% | $29.7B +6.0% | $28.0B +14.5% | $24.5B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $4.1B -14.0% | $4.7B +9.3% | $4.3B +10.4% | $3.9B +19.7% | $3.3B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 9.0% -2.7pp | 11.7% -1.1pp | 12.7% +0.4pp | 12.3% +0.5pp | 11.8% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $3.0B +9.7% | $2.7B +11.4% | $2.5B +6.5% | $2.3B +11.8% | $2.1B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $3.3B +8.7% | $3.0B +9.7% | $2.8B +8.5% | $2.5B +12.6% | $2.3B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $195.0M +4.8% | $186.0M +8.8% | $171.0M -2.8% | $176.0M +34.4% | $131.0M | $374.2M | $1.2B | $631.8M |
| EBITDA | $976.0M -48.4% | $1.9B +8.5% | $1.7B +29.3% | $1.3B +19.8% | $1.1B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 2.1% -2.5pp | 4.7% -0.5pp | 5.1% +0.9pp | 4.2% +0.2pp | 4.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | $781.0M -54.2% | $1.7B +8.5% | $1.6B +13.9% | $1.4B +35.4% | $1.0B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 1.7% -2.5pp | 4.2% -0.4pp | 4.6% +0.3pp | 4.3% +0.6pp | 3.7% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $192.0M +62.7% | $118.0M +8.3% | $109.0M -0.9% | $110.0M -8.3% | $120.0M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$192.0M -62.7% | -$118.0M -8.3% | -$109.0M +65.7% | -$318.0M -119.3% | -$145.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $589.0M -62.9% | $1.6B +8.5% | $1.5B +37.7% | $1.1B +21.5% | $875.0M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 1.3% -2.6pp | 3.9% -0.4pp | 4.3% +1.0pp | 3.3% +0.2pp | 3.2% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $117.0M -71.5% | $410.0M +9.9% | $373.0M +37.6% | $271.0M +25.5% | $216.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $472.0M -60.0% | $1.2B +8.1% | $1.1B +37.8% | $792.0M +20.2% | $659.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | 1.0% -1.9pp | 2.9% -0.3pp | 3.2% +0.7pp | 2.5% +0.1pp | 2.4% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $9 -56.5% | $21 +9.7% | $19 +36.6% | $14 +20.2% | $11 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $9 -56.3% | $20 +8.7% | $19 +38.7% | $14 +20.4% | $11 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $50.8M -11.5% | $57.4M -1.2% | $58.1M +0.5% | $57.8M +0.0% | $57.8M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $50.8M -12.0% | $57.7M -0.7% | $58.1M -0.7% | $58.5M -0.2% | $58.6M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
DaVita Inc.
NYSE:DVA
$13.48B
Globus Medical, Inc.
NYSE:GMED
$10.89B
Masimo Corporation
NASDAQ:MASI
$9.42B
Henry Schein, Inc.
NASDAQ:HSIC
$9.31B
Halozyme Therapeutics, Inc.
NASDAQ:HALO
$8.26B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.72B
AptarGroup, Inc.
NYSE:ATR
$7.53B
HealthEquity, Inc.
NASDAQ:HQY
$7.38B
Avantor, Inc.
NYSE:AVTR
$6.54B
Grifols, S.A.
NASDAQ:GRFS
$6.50B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does MOH generate?
Molina Healthcare, Inc. (MOH) reported $45.43B of revenue in fiscal 2025.
Is MOH profitable?
Molina Healthcare, Inc. (MOH) reported $472.00M of net income, with a net margin of 1.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.